IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q3 FY23 results · Oct–Dec 2022
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹523.48 crore and net profit of ₹23.79 crore for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 523.48 | — | — | 541.41 | −3.3% |
| Other income | 6.65 | — | — | 5.07 | +31.2% |
| Total income | 530.13 | — | — | 546.48 | −3.0% |
| Profit before tax | 32.89 | — | — | 22.14 | +48.6% |
| Net profit for the period | 23.79 | — | — | 15.91 | +49.5% |
| EPS, basic (₹) | 4.05 | — | — | 2.71 | +49.4% |
| Net margin (%) | 4.5 | — | 2.9 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 523.48 | 555.14 | −5.7% | 541.41 | −3.3% |
| Other income | 6.64 | 8.88 | −25.2% | 5.06 | +31.2% |
| Total income | 530.12 | 564.02 | −6.0% | 546.47 | −3.0% |
| Profit before tax | 33.25 | 54.67 | −39.2% | 21.90 | +51.8% |
| Net profit for the period | 24.15 | 40.07 | −39.7% | 15.67 | +54.1% |
| EPS, basic (₹) | 4.12 | 6.82 | −39.6% | 2.67 | +54.3% |
| Net margin (%) | 4.6 | 7.2 | 2.9 |
Consolidated
- Filed with BSE
- 08 Feb 2023, 12:56 IST
- Board meeting
- 07 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Feb 2023, 12:56 IST
- Board meeting
- 07 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Audited
- Source
- XBRL filing on BSE